Infliximab in ankylosing spondylitis: alone or in combination with ... - 7thSpace Interactive (press release)

Infliximab in ankylosing spondylitis: alone or in combination with ... 7thSpace Interactive (press release) However, its combination with infliximab in the treatment of ankylosing spondylitis (AS) is not recommended. The objective of this study was to study the influence of MTX on infliximab exposure in patients with AS. Methods: AS patients with ...

Baseline new bone formation does not predict bone loss in ankylosing ... - 7thSpace Interactive (press release)

Baseline new bone formation does not predict bone loss in ankylosing ... 7thSpace Interactive (press release) To evaluate the relationship between bone loss and new bone formation in ankylosing spondylitis (AS) using 10-year X-ray, dual-energy x-ray absorptiometry (DXA) and quantitative computed tomography (QCT) follow-up. Methods: Fifteen AS patients free ...

DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis - Skin and Allergy News Digital Network

DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis Skin and Allergy News Digital Network Data Source: The data come from a 9-year follow-up study from DANBIO involving 9164 rheumatoid arthritis, 1404 psoriatic arthritis, 1291 ankylosing spondylitis, and 1053 other arthritis patients treated with infliximab, etanercept, and adalimumab. ... and more »

The Spondylitis Association of America To Present a Patient Educational ... - PR Web (press release)

The Spondylitis Association of America To Present a Patient Educational ... PR Web (press release) On June 25th, the Spondylitis Association of America (SAA) will be at the The Hilton Nashville Downtown Hotel to present a free, one-day seminar on ankylosing spondylitis (AS), a chronic, rheumatic disease that generally strikes young people between ...